Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
European Archives of Psychiatry and Clinical Neuroscience

01-06-2014 | Original Paper

Gene expression in superior temporal cortex of schizophrenia patients

Published in: European Archives of Psychiatry and Clinical Neuroscience | Issue 4/2014

Login to get access

Abstract

We investigated gene expression pattern obtained from microarray data of 10 schizophrenia patients and 10 control subjects. Brain tissue samples were obtained postmortem; thus, the different ages of the patients at death also allowed a study of the dynamic behavior of the expression patterns over a time frame of many years. We used statistical tests and dimensionality reduction methods to characterize the subset of genes differentially expressed in the two groups. A set of 10 genes were significantly downregulated, and a larger set of 40 genes were upregulated in the schizophrenia patients. Interestingly, the set of upregulated genes includes a large number of genes associated with gene transcription (zinc finger proteins and histone methylation) and apoptosis. We furthermore identified genes with a significant trend correlating with age in the control (MLL3) or the schizophrenia group (SOX5, CTRL). Assessments of correlations of other genes with the disorder (RRM1) or with the duration of medication could not be resolved, because all patients were medicated. This hypothesis-free approach uncovered a series of genes differentially expressed in schizophrenia that belong to a number of distinct cell functions, such as apoptosis, transcriptional regulation, cell motility, energy metabolism and hypoxia.
Appendix
Available only for authorised users
Literature
1.
Murray CL, Lopez AD (1996) The global burden of disease. Harvard University Press, Cambridge
2.
Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, Cooper JE, Day R, Bertelsen A (1992) Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl 20:1–97PubMedCrossRef
3.
Häfner H, Riecher A, Maurer K, Löffler W, Munk-Jørgensen P, Strömgren E (1989) How does gender influence age at first hospitalization for schizophrenia? A transnational case register study. Psychol Med 19(4):903–918PubMedCrossRef
4.
Mendrek A, Lakis N, Jiménez J (2011) Associations of sex steroid hormones with cerebral activations during mental rotation in men and women with schizophrenia. Psychoneuroendocrinology 36(9):1422–1426PubMedCrossRef
5.
Diekhof EK, Kaps L, Falkai P, Gruber O (2012) The role of the human ventral striatum and the medial orbitofrontal cortex in the representation of reward magnitude—an activation likelihood estimation meta-analysis of neuroimaging studies of passive reward expectancy and outcome processing. Neuropsychologia 50(7):1252–1266PubMedCrossRef
6.
Ellison-Wright I, Bullmore E (2009) Meta-analysis of diffusion tensor imaging studies in schizophrenia. Schizophr Res 108(1–3):3–10PubMedCrossRef
7.
Hazlett EA, Buchsbaum MS, Haznedar MM, Newmark R, Goldstein KE, Zelmanova Y, Glanton CF, Torosjan Y, New AS, Lo JN, Mitropoulou V, Siever LJ (2008) Cortical gray and white matter volume in unmedicated schizotypal and schizophrenia patients. Schizophr Res 101(1–3):111–123PubMedCentralPubMedCrossRef
8.
Glantz LA, Lewis DA (1997) Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Arch Gen Psychiatry 54(7):660–669PubMedCrossRef
9.
Sokolov BP, Tcherepanov AA, Haroutunian V, Davis KL (2000) Levels of mRNAs encoding synaptic vesicle and synaptic plasma membrane proteins in the temporal cortex of elderly schizophrenic patients. Biol Psychiatry 48(3):184–196PubMedCrossRef
10.
Eastwood SL, Harrison PJ (2005) Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons. Schizophr Res 73(2–3):159–172PubMedCrossRef
11.
Meltzer HY, Stahl SM (1976) The dopamine hypothesis of schizophrenia: a review. Schizophr Bull 2(1):19–76PubMedCrossRef
12.
Olney JW, Farber NB (1995) Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:998–1007PubMedCrossRef
13.
Weinberger DR, Berman KF, Illowsky BP (1988) Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia III: a new cohort and evidence for a monoaminergic mechanism. Arch Gen Psychiatry 45:609–615PubMedCrossRef
14.
Cannon TD, Rosso IM, Bearden CE, Sanchez LE, Hadley T (1999) A prospective cohort study of neurodevelopmental processes in the genesis and epigenesis of schizophrenia. Dev Psychopathol 11(3):467–485PubMedCrossRef
15.
McNeil TF, Cantor-Graae E, Ismail B (2000) Obstetric complications and congenital malformation in schizophrenia. Brain Res Brain Res Rev 31(2–3):166–178PubMedCrossRef
16.
Dalman C, Thomas HV, David AS, Gentz J, Lewis G, Allebeck P (2001) Signs of asphyxia at birth and risk of schizophrenia. Population-based case-control study. Br J Psychiatry 179:403–408PubMedCrossRef
17.
Lederbogen F, Kirsch P, Haddad L, Streit F, Tost H, Schuch P, Wüst S, Pruessner JC, Rietschel M, Deuschle M, Meyer-Lindenberg A (2011) City living and urban upbringing affect neural social stress processing in humans. Nature 474(7352):498–501PubMedCrossRef
18.
19.
Fischer A, Sananbenesi F, Mungenast A, Tsai LH (2010) Targeting the correct HDAC(s) to treat cognitive disorders. Trends Pharmacol Sci 31(12):605–617PubMedCrossRef
20.
Schmitt A, Leonardi-Essmann F, Duerrenberger P, Parlapani E, Schneider-Axmann T, Spanagel R, Arzberger T, Kretzschmar H, Herrera-Marschitz M, Gruber O, Reynolds R, Falkai P, Gebicke-Haerter PJ (2011) Regulation of immune-modulatory genes in left superior temporal cortex of schizophrenia patients: a genome-wide microarray study. World J Biol Psychiatry 12:201–215PubMedCrossRef
21.
Nieuwenhuis R, Voogt J, van Huijzen C (1988) The human central nervous system—a synopsis and atlas, 3rd edn. Springer, BerlinCrossRef
22.
Galletly CA, Tsourtos G (1997) Antipsychotic drug doses and adjunctive drugs in the outpatient treatment of schizophrenia. Ann Clin Psychiatry 9(2):77–80PubMedCrossRef
23.
Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112(4):389–404PubMedCentralPubMedCrossRef
24.
Antonova E, Kumari V, Morris R, Halari R, Anilkumar A, Mehrotra R, Sharma T (2005) The relationship of structural alterations to cognitive deficits in schizophrenia: a voxel-based morphometry study. Biol Psychiatry 58(6):457–467PubMedCrossRef
25.
Hazlett EA, Buchsbaum MS, Zhang J, Newmark RE, Glanton CF, Zelmanova Y, Haznedar MM, Chu KW, Nenadic I, Kemether EM, Tang CY, New AS, Siever LJ (2008) Frontal-striatal-thalamic mediodorsal nucleus dysfunction in schizophrenia-spectrum patients during sensorimotor gating. Neuroimage 42(3):1164–1177PubMedCentralPubMedCrossRef
26.
Mechelli A, Allen P, Amaro E Jr, Fu CH, Williams SC, Brammer MJ, Johns LC, McGuire PK (2007) Misattribution of speech and impaired connectivity in patients with auditory verbal hallucinations. Hum Brain Mapp 28(11):1213–1222PubMedCrossRef
27.
Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M, Lightfoot S, Menzel W, Granzow M, T Ragg (2006) The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 7:3PubMedCentralPubMedCrossRef
28.
29.
Ringnér M (2008) What is principal component analysis? Nat Biotech 26(3):303–304CrossRef
30.
31.
Saldanha AJ (2004) Java Treeview—extensible visualization of microarray data. Bioinformatics 20(17):3246–3248PubMedCrossRef
32.
Spearman C (1904) The proof and measurement of association between two things. Am J Psychol 15(1):72–101CrossRef
33.
Best DJ, Roberts DE (1975) Algorithm AS 89: the upper tail probabilities of Spearman’s rho. J R Stat Soc Ser C Appl Stat) 24(3):377–379
34.
35.
Koutsouleris N, Davatzikos C, Borgwardt S, Gaser C, Bottlender R, Frodl T, Falkai P, Riecher-Rössler A, Möller HJ, Reiser M, Pantelis C, Meisenzahl E (2013) Accelerated brain aging in schizophrenia and beyond: a neuroanatomical marker of psychiatric disorders. Schizophr Bull. doi:10.​1093/​schbul/​sbt142
36.
Lee S, Lee DK, Dou Y, Lee J, Lee B, Kwak E, Kong YY, Lee SK, Roeder RG, Lee JW (2006) Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases. Proc Natl Acad Sci USA 103(42):15392–15397PubMedCentralPubMedCrossRef
37.
Ruthenburg AJ, Allis CD, Wysocka J (2007) Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell 25(1):15–30PubMedCrossRef
38.
Ansari KI, Kasiri S, Hussain I, Mandal SS (2009) Mixed lineage leukemia histone methylases play critical roles in estrogen-mediated regulation of HOXC13. FEBS J 276(24):7400–7411PubMedCrossRef
39.
Lee S, Kim DH, Goo YH, Lee YC, Lee SK, Lee JW (2009) Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation. Mol Endocrinol 23(5):610–619PubMedCentralPubMedCrossRef
40.
Lee S, Lee J, Lee SK, Lee JW (2008) Activating signal cointegrator-2 is an essential adaptor to recruit histone H3 lysine 4 methyltransferases MLL3 and MLL4 to the liver X receptors. Mol Endocrinol 22(6):1312–1319PubMedCentralPubMedCrossRef
41.
Huang HS, Matevossian A, Whittle C, Kim SY, Schumacher A, Baker SP, Akbarian S (2007) Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters. J Neurosci 27(42):11254–11262PubMedCrossRef
42.
Wynder C, Hakimi MA, Epstein JA, Shilatifard A, Shiekhattar R (2005) Recruitment of MLL by HMG-domain protein iBRAF promotes neural differentiation. Nat Cell Biol 7(11):1113–1117PubMedCrossRef
43.
Gupta S, Kim SY, Artis S, Molfese DL, Schumacher A, Sweatt JD, Paylor RE, Lubin FD (2010) Histone methylation regulates memory formation. J Neurosci 30(10):3589–3599PubMedCentralPubMedCrossRef
44.
Boyer LA, Plath K, Zeitlinger J, Brambrink T, Mederios LA, Lee TI, Levine SS, Wernig M, Tajonar A, Ray MK et al (2006) Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441:349–353PubMedCrossRef
45.
Fujimura Y, Isono K, Vidal M, Endoh M, Kajita H, Mizutani-Koseki Y, Takihara Y, Van Lohuizen M, Otte AP, Jenuwein T et al (2006) Distinct roles of Polycomb group gene products in transcriptionally repressed and active domains of Hoxb8. Development 133(2371–2381):2006
46.
Maris C, Dominguez C, Allain FH (2005) The RNA recognition motif, a plastic RNA-binding platform to regulate post-transcriptional gene expression. FEBS J 272(9):2118–2131PubMedCrossRef
47.
Blanton S, Srinivasan A, Rymond BC (1992) PRP38 encodes a yeast protein required for pre-mRNA splicing and maintenance of stable U6 small nuclear RNA levels. Mol Cell Biol 12:3939–3947PubMedCentralPubMed
48.
49.
Martins-de-Souza D, Gattaz WF, Schmitt A, Novello JC, Marangoni S, Turck CW, Dias-Neto E (2009) Proteome analysis of schizophrenia patients Wernicke’s area reveals an energy metabolism dysregulation. BMC Psychiatry 9:17PubMedCentralPubMedCrossRef
50.
Iwata K, Matsuzaki H, Manabe T, Mori N (2011) Altering the expression balance of hnRNP C1 and C2 changes the expression of myelination-related genes. Psychiatry Res 190(2–3):364–366PubMedCrossRef
51.
Agoston Z, Schulte D (2009) Meis2 competes with the Groucho co-repressor Tle4 for binding to Otx2 and specifies tectal fate without induction of a secondary midbrain-hindbrain boundary organizer. Development 136(19):3311–3322PubMedCrossRef
52.
Riveros C, Mellor D, Gandhi KS, McKay FC, Cox MB, Berretta R, Vaezpour SY, Inostroza-Ponta M, Broadley SA, Heard RN, Vucic S, Stewart GJ, Williams DW, Scott RJ, Lechner-Scott J, Booth DR, Moscato P (2010) ANZgene multiple sclerosis genetics consortium. A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis. PLoS One 5(12):e14176PubMedCentralPubMedCrossRef
53.
Martinez-Morales PL, Quiroga AC, Barbas JA, Morales AV (2010) SOX5 controls cell cycle progression in neural progenitors by interfering with the WNT-beta-catenin pathway. EMBO Rep 11(6):466–472PubMedCentralPubMedCrossRef
54.
Baillat D, Hakimi MA, Näär AM, Shilatifard A, Cooch N, Shiekhattar R (2005) Integrator, a multiprotein mediator of small nuclear RNA processing, associates with the C-terminal repeat of RNA polymerase II. Cell 123(2):265–276PubMedCrossRef
55.
Wang LR, Zhang GB, Chen J, Li J, Li MW, Xu N, Wang Y (2011) Shen Tu JZ. RRM1 gene expression in peripheral blood is predictive of shorter survival in Chinese patients with advanced non-small-cell lung cancer treated by gemcitabine and platinum. J Zhejiang Univ Sci B 12(3):174–179PubMedCentralPubMedCrossRef
56.
Abad PC, Lewis J, Mian IS, Knowles DW, Sturgis J, Badve S, Xie J, Lelièvre SA (2007) NuMA influences higher order chromatin organization in human mammary epithelium. Mol Biol Cell 18(2):348–361PubMedCentralPubMedCrossRef
57.
Rubio MD, Wood K, Haroutunian V, Meador-Woodruff JH (2013) Dysfunction of the ubiquitin proteasome and ubiquitin-like systems in schizophrenia. Neuropsychopharmacology 38(10):1910–1920PubMedCrossRef
58.
Fu X, Yucer N, Liu S, Li M, Yi P, Mu JJ, Yang T, Chu J, Jung SY, O’Malley BW, Gu W, Qin J, Wang Y (2010) RFWD3-Mdm2 ubiquitin ligase complex positively regulates p53 stability in response to DNA damage. Proc Natl Acad Sci USA 107(10):4579–4584PubMedCentralPubMedCrossRef
59.
Yuan Z, Villagra A, Peng L, Coppola D, Glozak M, Sotomayor EM, Chen J, Lane WS, Seto E (2010) The ATDC (TRIM29) protein binds p53 and antagonizes p53-mediated functions. Mol Cell Biol 30(12):3004–3015PubMedCentralPubMedCrossRef
60.
Huang CJ, Yang SH, Huang SM, Lin CM, Chien CC, Chen YC, Lee CL, Wu HH, Chang CC (2011) A predicted protein, KIAA0247, is a cell cycle modulator in colorectal cancer cells under 5-FU treatment. J Transl Med 9:82PubMedCentralPubMedCrossRef
61.
Saeki N, Kim DH, Usui T, Aoyagi K, Tatsuta T, Aoki K, Yanagihara K, Tamura M, Mizushima H, Sakamoto H, Ogawa K, Ohki M, Shiroishi T, Yoshida T, Sasaki H (2007) GASDERMIN, suppressed frequently in gastric cancer, is a target of LMO1 in TGF-beta-dependent apoptotic signalling. Oncogene 26(45):6488–6498PubMedCrossRef
62.
Valdivia CR, Ueda K, Ackerman MJ, Makielski JC (2009) GPD1L links redox state to cardiac excitability by PKC-dependent phosphorylation of the sodium channel SCN5A. Am J Physiol Heart Circ Physiol 297(4):H1446–H1452PubMedCentralPubMedCrossRef
63.
Slepak T, Tang M, Addo F, Lai K (2005) Intracellular galactose-1-phosphate accumulation leads to environmental stress response in yeast model. Mol Genet Metab 86(3):360–371PubMedCrossRef
64.
Berry GT (2011) Is prenatal myo-inositol deficiency a mechanism of CNS injury in galactosemia? J Inherit Metab Dis 34(2):345–355PubMedCrossRef
65.
Martins-de-Souza D, Harris LW, Guest PC, Bahn S (2011) The role of energy metabolism dysfunction and oxidative stress in schizophrenia revealed by proteomics. Antioxid Redox Signal 15(7):2067–2079PubMedCrossRef
66.
Gess B, Hofbauer KH, Wenger RH, Lohaus C, Meyer HE, Kurtz A (2003) The cellular oxygen tension regulates expression of the endoplasmic oxidoreductase ERO1-Lalpha. Eur J Biochem 270(10):2228–2235PubMedCrossRef
67.
Schmidt-Kastner R, van Os J, Steinbusch HWM, Schmitz C (2006) Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia. Schizophr Res 84(2–3):253–271PubMedCrossRef
68.
Korennykh AV, Egea PF, Korostelev AA, Finer-Moore J, Zhang C, Shokat KM, Stroud RM, Walter P (2009) The unfolded protein response signals through high-order assembly of Ire1. Nature 457(7230):687–693PubMedCentralPubMedCrossRef
69.
Huehnchen P, Prozorovski T, Klaissle P, Lesemann A, Ingwersen J, Wolf SA, Kupsch A, Aktas O, Steiner B (2011) Modulation of adult hippocampal neurogenesis during myelin-directed autoimmune neuroinflammation. Glia 59(1):132–142PubMedCrossRef
70.
van de Pavert SA, Meuleman J, Malysheva A, Aartsen WM, Versteeg I, Tonagel F, Kamphuis W, McCabe CJ, Seeliger MW, Wijnholds J (2007) A single amino acid substitution (Cys249Trp) in Crb1 causes retinal degeneration and deregulates expression of pituitary tumor transforming gene Pttg1. J Neurosci 27(3):564–573PubMedCrossRef
71.
Setty Y, Chen CC, Secrier M, Skoblov N, Kalamatianos D, Emmott S (2011) How neurons migrate: a dynamic in silico model of neuronal migration in the developing cortex. BMC Syst Biol 5:154PubMedCentralPubMedCrossRef
72.
Schmitt A, Turck CW, Pilz PK, Malchow B, von Wilmsdorff M, Falkai P, Martins-de-Souza D (2013) Proteomic similarities between heterozygous reeler mice and schizophrenia. Biol Psychiatry 74(6):e5–e10PubMedCrossRef
73.
Angers M, Uldry M, Kong D, Gimble JM, Jetten AM (2008) Mfsd2a encodes a novel major facilitator superfamily domain-containing protein highly induced in brown adipose tissue during fasting and adaptive thermogenesis. Biochem J 416(3):347–355PubMedCentralPubMedCrossRef
74.
Johansson M, Rocha N, Zwart W, Jordens I, Janssen L, Kuijl C, Olkkonen VM, Neefjes J (2007) Activation of endosomal dynein motors by stepwise assembly of Rab7-RILP-p150Glued, ORP1L, and the receptor betalll spectrin. J Cell Biol 176(4):459–471PubMedCentralPubMedCrossRef
75.
Kato A, Okamoto O, Ishikawa K, Sumiyoshi H, Matsuo N, Yoshioka H, Nomizu M, Shimada T, Fujiwara S (2011) Dermatopontin interacts with fibronectin, promotes fibronectin fibril formation, and enhances cell adhesion. J Biol Chem 286(17):14861–14869PubMedCentralPubMedCrossRef
76.
Aston C, Jiang L, Sokolov BP (2004) Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosci Res 77:858–866PubMedCrossRef
77.
78.
Vawter MP, Tanya Barrett T, Cheadle C, Sokolov BP, Wood WH III, Donovan DM, Webster M, Freed WJ, Becker KG (2011) Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res Bull 55(5):641–650CrossRef
Metadata
Title
Gene expression in superior temporal cortex of schizophrenia patients
Publication date
01-06-2014
Published in
European Archives of Psychiatry and Clinical Neuroscience / Issue 4/2014
Print ISSN: 0940-1334
Electronic ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-013-0473-5